affymax inc (AFFY:NASDAQ GS)

Executive Profile*

Background*

Mr. John A. Orwin served as the Chief Executive Officer of Affymax, Inc. from February 1, 2011 to May 15, 2013. Mr. Orwin is an Executive with over 20 years of experience in the biotechnology and pharmaceutical industries. Mr. Orwin served as the President and Chief Operating Officer of Affymax Inc. from April 2010 to January 2011. Mr. Orwin served as Senior Vice President of Sales & Marketing - Bio Oncology of Genentech Inc. since January 17, 2007. Mr. Orwin served ... as a Vice President of Bio Oncology of Genentech Inc., until January 17, 2007. He served as a Vice President of Human EGF-Receptor (HER) Family Product Sales and Marketing of Genentech Inc., since December 2004. Mr. Orwin was responsible for leadership and development of the HER family product portfolio, including sales and marketing activities, and the business's life cycle plans. Mr. Orwin joined Genentech from Johnson & Johnson's Ortho Biotech division, where he served as Franchise Vice President, Oncology of the Tibotec Therapeutics group. He has held Senior Marketing and Sales Positions with Schering-Plough Corporation, Rhone-Poulenc Rorer Pharmaceuticals, Sangstat Medical Corporation and Alza Pharmaceuticals. He has been a Director of Affymax, Inc., since February 01, 2011. He has been a Director of Array BioPharma, Inc., since November 6, 2012. He has been an Independent Director of NeurogesX, Inc. since November 19, 2009. He has been a Director and a Member of Emerging Companies Section Governing Board at Biotechnology Industry Organization since July 2011. Mr. Orwin holds a Master of Business Administration from the Stern School of Business, New York University and a Bachelor of Arts degree in Economics from Rutgers University.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
AFFY:US	$1.39 USD	-0.01

COMPETITOR COMPENSATION